HCA Healthcare's Dr. Jane Englebright Named Board Chair of The Joint Commission Board of Commissioners

MEDITECH is pleased to congratulate Dr. Jane Englebright, HCA Healthcare’s (Nashville, TN) chief nurse executive and senior vice president, for being appointed as board chair of The Joint Commission Board of Commissioners. Dr. Englebright will begin her new role on January 1, 2021.

As board chair, Dr. Englebright will provide strategic direction and oversight to aid in The Joint Commission’s mission to continuously improve healthcare. Her dedication to advancing nursing through innovative practices supports The Joint Commission’s ongoing response to the COVID-19 crisis.

“Congratulations to Dr. Englebright on being named board chair of The Joint Commission Board of Commissioners," said MEDITECH Associate Vice President Cathy Turner, BSN, MBA, RN-BC. “Dr. Englebright’s dedication to technology and innovation, and her commitment to optimizing care delivery at HCA Healthcare make her an ideal choice for the role. I’m confident she will excel as she continues to promote quality care at a national level.”

Dr. Englebright has been a member of the Joint Commission Board of Commissioners since 2014, first as nursing at large commissioner and most recently as vice chair. She began her nursing career with HCA Healthcare in 1992 as a critical care nurse. Now, as chief nurse executive and senior vice president, Dr. Englebright provides leadership for approximately 94,000 registered nurses working in HCA Healthcare hospitals, ambulatory surgery centers, and other care sites.

HCA Healthcare is an American investor-owned operator of health care facilities that was founded in 1968. As one of the nation's leading providers of healthcare services, HCA Healthcare comprises more than 180 hospitals and 2,000+ sites of care in 21 states and the United Kingdom.